Jonathan Mauer Email & Phone Number

New York, New York, US

• Supported International Development Market Team to address threat to Toviaz reimbursement by EU Health Authority; led workshop and developed favorable benefit risk conclusion validated and published results with key.
• Led benefit-risk workshop to guide submission strategy and prepare key messages for communication conclusions to regulators; provided data, key to gaining regulatory approval by assisting team in communicating.
• Designed online self-service system, enabling teams to complete benefit risk frameworks collaboratively to improve efficiency of drafting and transferring documents into electronic regulatory submission system.
• Served as Pfizer Medical decision quality expert and surveyed stakeholders in medical decision forums to establish best practices and identify opportunities to enhance compliance and risk management.
• Devised value-based tools and processes, validated by external bioethics panel, to help company executives make difficult trade-off decisions in times of simultaneous manufacturing shortages requiring prioritization of.

New York, New York, US

• Designed, implemented, and managed analytic processes to guide asset and portfolio strategy, seize internal/external business development opportunities, and optimize $10B portfolio.
• Supported enterprise R&D portfolio decision making involving allocation of $7B annual R&D budget.
• Played key role in company’s decision to exit partnership involving under-performing brand by delivering data, building models, and developing strategic options to resolve issue between partner and Pfizer.
• Influenced over 6 industry approvals by guiding public policy negotiations with economic analysis supporting Generating Antibiotic Incentives Now (GAIN Act) signed into law by President Obama.
• Developed core elements of policy position on market-based incentives to finance healthcare innovation; represented policy position in external forums for bill under consideration in Congress.
• Directed Neuroscience & Pain strategy and operations planning; guided Executives’ decision to exit research in pain management, redirecting funds to higher impact projects.

Lawrence Township, NJ, US

• Managed $5M budget for 3 partnered early development oncology assets with 12 core team members per asset and additional external resources.

Lawrence Township, NJ, US

• Removed $750M from BMS R&D budget enabling portfolio diversification across multiple disease areas.
• Directed all aspects of Eliquis business insights analytics and assisted in guiding deal structure decision making in partnership with Pfizer.
• Guided complex decision making in $7.8B acquisition of DuPont by evaluating and integrating technical risk, commercial uncertainty, and R&D portfolio integration.

Lawrence Township, NJ, US

Delivered IT solutions and process improvements to customers in Clinical Development and Commercial Operations

US

Pediatric & Neonatal Intensive Care Pharmacist

Mba, Finance

Bs, Pharmacy

Ba, Biology